Pulse Biosciences, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-25.6M | $-9.5M | $-2.8M |
| Depreciation & Amortization | — | — | — |
| Depreciation | $336.0K | $94.0K | $51.0K |
| Amortization | $665.0K | $665.0K | $666.0K |
| Stock-Based Compensation | $10.9M | $870.0K | $402.0K |
| Net Cash from Operating Activities | $-11.1M | $-8.1M | $-3.3M |
| Investing Activities | |||
| Capital Expenditures | $2.6M | $64.0K | $86.0K |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-23.0M | $-14.4M | $-86.0K |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $35.4M | $20.9M | — |
| Net Change in Cash | $1.3M | $-1.5M | $-3.4M |
| Free Cash Flow | $-13.6M | $-8.1M | $-3.4M |